Inspire Medical Systems, Inc. (INSP)

Market Cap	1.56B -68.0%
Revenue (ttm)	911.98M +13.6%
Net Income	145.42M +171.8%
EPS	4.89 +179.4%
Shares Out	28.80M
PE Ratio	11.05
Forward PE	27.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,400,126
Open	56.00
Previous Close	56.69
Day's Range	52.92 - 57.10
52-Week Range	48.30 - 163.35
Beta	0.86
Analysts	Buy
Price Target	95.50 (+76.79%)
Earnings Date	May 4, 2026

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open ai...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,333
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Financial Performance

In 2025, Inspire Medical Systems's revenue was $911.98 million, an increase of 13.60% compared to the previous year's $802.80 million. Earnings were $145.42 million, an increase of 171.77%.

Analyst Summary

According to 16 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $95.5, which is an increase of 76.79% from the latest price.

Price Target

$95.5

(76.79% upside)

Analyst Consensus: Buy